Published in Infect Agent Cancer on May 17, 2007
A Role for RNA Viruses in the Pathogenesis of Burkitt's Lymphoma: The Need for Reappraisal. Adv Hematol (2011) 0.80
Epstein-Barr virus infection. N Engl J Med (2000) 5.93
Endemic Burkitt's lymphoma: a polymicrobial disease? Nat Rev Microbiol (2005) 1.83
Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival. Cancer (1991) 1.81
A case-control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda. Int J Cancer (2001) 1.75
HIV-associated malignant lymphomas in Kenya (Equatorial Africa) Hum Pathol (1998) 1.66
Cell-mediated immunity in nutritional deficiency. Prog Food Nutr Sci (1984) 1.56
Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1. J Natl Cancer Inst (1994) 1.41
Infection of human B cells with Epstein-Barr virus results in the expression of somatic hypermutation-inducing molecules and in the accrual of oncogene mutations. Mol Immunol (2006) 1.28
Non-Hodgkin lymphoma in Uganda: a case-control study. AIDS (2000) 1.25
Role of TH1/TH2 cytokines in HIV infection. Immunol Rev (1994) 1.22
Epidemiological evidence for the role of falciparum malaria in the pathogenesis of Burkitt's lymphoma. IARC Sci Publ (1985) 1.21
Effect of a malaria suppression program on the incidence of African Burkitt's lymphoma. Am J Epidemiol (1989) 1.21
Spectrum and presentation of pediatric malignancies in the HIV era: experience from Blantyre, Malawi, 1998-2003. Pediatr Blood Cancer (2007) 1.20
Childhood cancers in Zambia before and after the HIV epidemic. Arch Dis Child (1995) 1.19
Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study. Lancet (2006) 1.17
Persistent immunologic stimulation as a factor in oncogenesis, with special reference to Burkitt's tumor. Am J Med (1970) 1.15
The expression and function of Epstein-Barr virus encoded latent genes. Mol Pathol (2000) 1.12
Nutritional deficiency, immunologic function, and disease. Am J Pathol (1976) 1.11
Burkitt's lymphoma in the Mengo Districts of Uganda: epidemiologic features and their relationship to malaria. J Natl Cancer Inst (1976) 1.10
International variations in the incidence of childhood lymphomas. Paediatr Perinat Epidemiol (1990) 1.04
Pathogenesis of AIDS lymphomas. AIDS (1994) 1.03
Long-term experience with Burkitt's lymphoma in Uganda. Int J Cancer (1980) 1.03
Burkitt's lymphoma in adults with and without human immunodeficiency virus infection: a single-institution clinicopathologic study of 75 patients. Cancer (1998) 1.03
Adult Burkitt's lymphoma in patients with and without human immunodeficiency virus infection in Kenya. Int J Cancer (2001) 1.02
Elevated expression of c-myc in lymphoblastoid cells does not support an Epstein-Barr virus latency III-to-I switch. J Gen Virol (2001) 0.89
In vitro analysis of Epstein-Barr virus: host balance in patients with acute Plasmodium falciparum malaria. I. Defective T-cell control. Parasitol Res (1990) 0.89
The distribution of non-Burkitt, non-Hodgkin's lymphomas in Uganda in relation to malarial endemicity. Int J Cancer (1990) 0.89
Plasmodium falciparum products enhance human lymphocyte transformation by Epstein-Barr virus. Clin Exp Immunol (1984) 0.89
Nutritional modulation of immune responses. Fed Proc (1980) 0.88
HIV-associated lymphoma in Africa: an autopsy study in Cote d'Ivoire. Int J Cancer (1994) 0.86
Epidemiology of Burkitt's lymphoma. Proc R Soc Med (1971) 0.85
Intraclonal molecular heterogeneity suggests a hierarchy of pathogenetic events in Burkitt's lymphoma. Ann Oncol (1997) 0.85
[Lymphoma genesis in the context of HIV infection]. Ann Med Interne (Paris) (2003) 0.84
Kaposi's sarcoma and non-Hodgkin's lymphomas in children and adolescents with AIDS. AIDS (1996) 0.83
B-cell posttransplant lymphoproliferative disorders in heart and/or lungs recipients: clinical and molecular-histogenetic study of 17 cases from a single institution. Transplantation (2006) 0.81
Seroprevalence of human immunodeficiency virus type 1 infection in childhood malignancy in Zimbabwe. Cent Afr J Med (1998) 0.79
Nutrition and cellular immunity. Int J Immunopharmacol (1992) 0.78
[Lymphomas in the acquired human immunodeficiency syndrome. Clinical, histological, immunological, and developmental study of 26 patients]. Sangre (Barc) (1992) 0.77
Hypothesis of the cause and development of neoplasms. Eur J Cancer Prev (2007) 0.77
Epstein-Barr virus and malaria in relation to Burkitt's lymphoma in Papua New Guinea. P N G Med J (1986) 0.76